We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Liquid Cystatin C Assay– a Good Indicator of GFR

By LabMedica International staff writers
Posted on 27 Dec 2011
Print article
A liquid ready-to-use cystatin C assay provides a good indicator of glomerular filtration rate (GRF). As a more sensitive maker of renal dysfunction, cystatin C offers several advantages over traditional creatinine assays.

Cystatin C is unaffected by nonrenal factors including muscle mass, weight, height, age, gender, diet and drugs. Therefore it is particularly useful in cases where creatinine measurement is not appropriate e.g., in individuals who are obese, malnourished, or who have liver disease.

The Randox (Crumlin, United Kingdom) cystatin C assay is based on an immunoturbidimetric method and is suitable for use on a wide range of chemistry analyzers. All reagents are supplied liquid ready to use for added convenience; furthermore, reagents are stable for 28 days at +10 °C onboard the analyzer, minimizing the possibility of reagent waste.

The assay has a wide measuring range of 0.4 to 10 mg/L allowing both normal and abnormal values to be measured accurately and reliably without the need for additional dilutions. Further benefits include precision (CVs under 5%) and limited interference from bilirubin, hemoglobin, triglycerides, and intralipids. A full range of supporting quality controls and calibrators are also available.

Cystatin C is sensitive to changes in the “creatinine blind” range enabling detection of early reductions in GFR and subsequent early treatment of kidney disease. Cystatin C has several other advantages over creatinine; the ability of cystatin C to detect even small changes in GFR makes it the ideal marker for dosing medication eliminated by the kidneys. Cystatin C is also the preferred marker for estimating GFR in infants, the elderly, diabetics, and those with reduced muscle mass.

Traditionally creatinine was the most widely used marker of GFR and kidney function but several recent studies have documented cystatin C as a far superior and sensitive marker. Cystatin C is produced at a constant rate throughout the body and is removed and broken down by the kidneys, levels will therefore remain steady if the kidneys are working efficiently and the GFR is normal.

The prevalence of chronic kidney disease continues to increase dramatically as does the burden on healthcare resources. The early detection of kidney disease is crucial in order to lower healthcare costs, avoid disease progression, and reduce the need for dialysis or transplantation.

Related Links:

Randox

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.